Lange PH - Search Results

1

[In vitro and in vivo models developed from human prostatic cancer].

Bladou F, Gleave ME, Penault-Llorca F, Serment G, Lange PH, Vessella RL. Bladou F, et al. Among authors: lange ph. Prog Urol. 1997 Jun;7(3):384-96. Prog Urol. 1997. PMID: 9273065 Review. French.

2

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.

Liu AY, Corey E, Bladou F, Lange PH, Vessella RL. Liu AY, et al. Among authors: lange ph. Int J Cancer. 1996 Jan 3;65(1):85-9. doi: 10.1002/(SICI)1097-0215(19960103)65:1<85::AID-IJC15>3.0.CO;2-H. Int J Cancer. 1996. PMID: 8543402

3

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.

Bladou F, Vessella RL, Buhler KR, Ellis WJ, True LD, Lange PH. Bladou F, et al. Among authors: lange ph. Int J Cancer. 1996 Sep 17;67(6):785-90. doi: 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N. Int J Cancer. 1996. PMID: 8824549

4

Preclinical models of prostate cancer.

Royai R, Lange PH, Vessella R. Royai R, et al. Among authors: lange ph. Semin Oncol. 1996 Dec;23(6 Suppl 14):35-40. Semin Oncol. 1996. PMID: 8996584 Review.

5

Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.

Melchior SW, Brown LG, Figg WD, Quinn JE, Santucci RA, Brunner J, Thüroff JW, Lange PH, Vessella RL. Melchior SW, et al. Among authors: lange ph. Int J Oncol. 1999 Mar;14(3):501-8. doi: 10.3892/ijo.14.3.501. Int J Oncol. 1999. PMID: 10024683

6

Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Ellis WJ, et al. Among authors: lange ph. Clin Cancer Res. 1996 Jun;2(6):1039-48. Clin Cancer Res. 1996. PMID: 9816265

7

Newer applications of serum prostate-specific antigen in the management of prostate cancer.

Takayama TK, Vessella RL, Lange PH. Takayama TK, et al. Among authors: lange ph. Semin Oncol. 1994 Oct;21(5):542-53. Semin Oncol. 1994. PMID: 7524153 Review.

8

Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.

Lange PH, Vessella RL. Lange PH, et al. Cancer Metastasis Rev. 1998-1999;17(4):331-6. doi: 10.1023/a:1006106209527. Cancer Metastasis Rev. 1998. PMID: 10453276 Review.

9

Differential expression of osteonectin/SPARC during human prostate cancer progression.

Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL. Thomas R, et al. Among authors: lange ph. Clin Cancer Res. 2000 Mar;6(3):1140-9. Clin Cancer Res. 2000. PMID: 10741745

10

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.

Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. Ercole CJ, et al. Among authors: lange ph. J Urol. 1987 Nov;138(5):1181-4. doi: 10.1016/s0022-5347(17)43543-9. J Urol. 1987. PMID: 2444720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters